Details.
A study investigating an experimental new medicine for problems with thinking such as memory and concentration, linked to brain disorders like Alzheimer’s disease and schizophrenia. For healthy males or females aged 18 to 55 with a BMI of 18 to 30.9 kg/m2. The study involves 2 to 4 nights and at least 2 clinical visits. Start date: 3 September 2026. Study payment: £1,250 to £2,315.